Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injection site pain study of subcutaneous excipient solutions in healthy adults
NL-OMON50101Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Normal Saline-Benha University, sponsored by Novo Nordisk. Primary endpoint: Intensity of injection site pain. Started Jul 2020; status: completed.
02
Drugs
Normal Saline-Benha University
Beyond the preview
Go deeper on NL-OMON50101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50101.